Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Pacific Biosciences of California Company Profile (NASDAQ:PACB)

Consensus Ratings for Pacific Biosciences of California (NASDAQ:PACB) (?)
Ratings Breakdown: 4 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $7.95 (29.27% upside)

Analysts' Ratings History for Pacific Biosciences of California (NASDAQ:PACB)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/31/2015StephensInitiated CoverageEqual Weight$6.50ViewTweet This Rating  Share This Rating on StockTwits
2/4/2015Maxim GroupBoost Price TargetBuy$10.00 -> $11.00ViewTweet This Rating  Share This Rating on StockTwits
11/18/2014ZacksDowngradeOutperform -> Neutral$7.30ViewTweet This Rating  Share This Rating on StockTwits
10/20/2014ZacksUpgradeNeutral -> Outperform$6.00ViewTweet This Rating  Share This Rating on StockTwits
5/1/2014Deutsche BankUpgradeNeutralViewTweet This Rating  Share This Rating on StockTwits
5/1/2014JPMorgan Chase & Co.UpgradeUnderweight -> Neutral$7.00ViewTweet This Rating  Share This Rating on StockTwits
9/26/2013Maxim GroupBoost Price TargetBuy$4.00 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/19/2013 forward)